Fesoterodine
![Toviaz) Reference Number: ERX.ST.16 Effective Date: 09.01.17 Last Review Date: 08.17 Line of Business: Commercial [Prescription Drug Plan] Revision Log](http://data.docslib.org/img/264x/133f7c464ab664d04ee26df0397853aa.webp)
Top View
- Overactive Bladder Agents Reference Number: CP.PMN.198 Effective Date: 05.01.16 Last Review Date: 08.20 Revision Log Line of Business: Commercial, HIM, Medicaid
- Trospium Chloride Transport by Mouse Drug Carriers of the Slc22 and Slc47 Families
- Oral Medicines for the Management of Urinary Incontinence, Frequency & Overactive Bladder
- Use of Overactive Bladder Medications in the Adult Population Of
- Safety and Tolerability Profiles of Anticholinergic Agents Used for the Treatment of Overactive Bladder Michael G
- Bladder Relaxant Preparations
- Pharmacologic Treatment of Overactive Bladder
- Contraindications
- Ep 2554184 B1
- Green Chemistry
- Where Will I Have My Urodynamic Test? the Test Is Carried out in CQMI
- Neurologic Urinary and Faecal Incontinence
- NYSDOH Uninsured Care Programs Covered Services and ADAP
- Urinary Incontinence
- Preferred Drug List (PDL)
- Urinary Frequency Tom Kincer, MD Program Director Clinical Professor of Medicine Montgomery Family Medicine Residency
- NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
- Toviaz (Fesoterodine)